Polycythemia vera (PV)

What is polycythemia vera?

Research‑backed patient education is central to MPN Research Foundation’s mission. People living with polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs) deserve clear, accurate information they can trust to understand their diagnosis, symptoms, and treatment options.

What you’ll find inside:

  • Short animated explainers that break down complex topics in minutes
  • Expert‑led FAQ videos answering common patient questions
  • Patient experience stories that reflect real‑world challenges and insights

Watch the You and MPN: An Animated Patient’s Guide – Polycythemia Vera Module to learn more about this diagnosis.

References
  1. MPN Research Foundation. What is polycythemia vera? https://mpnresearchfoundation.org/polycythemia-vera-pv
  2. Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023 Sep;98(9):1465-1487.
  3. Thapa B, Fazal S, Parsi M, Rogers HJ. Myeloproliferative Neoplasms. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
    https://www.ncbi.nlm.nih.gov/books/NBK531464
  4. National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients: Myeloproliferative neoplasms. Version 2024. https://www.nccn.org/patients/guidelines/content/PDF/mpn-patient.pdf
  5. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022 Jul;36(7):1703-1719.

Join the MPN Research community

Be the first to know about the latest news and advancements.
RON
POLYCYTHEMIA VERA (PV)

Learn how Ron continues his cycling passion despite his PV diagnosis.